AVITA Medical, Inc. (NASDAQ: RCEL) reported Q4 EPS of ($0.21), $0.03 better than the analyst estimate of ($0.24). Revenue for the quarter came in at $9.46 million versus the consensus estimate of $8.8 million.

For earnings history and earnings-related data on AVITA Medical, Inc. (RCEL) click here.